Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Sollinger, Stefan"'
Autor:
Ferreira, Joaquim J, Godinho, Catarina, Santos, Ana T., Domingos, Josefa, Abreu, Daisy, Lobo, Raquel, Larsen, Frank Atle, Fagerbakke, Øyvind, Akeren, Ingvild, Wangen, Hilde, Serrano, Artur, Weber, Peter, Thoms, Andrea, Meckler, Stefan, Sollinger, Stefan, Uem, Janet van, Hobert, Markus A, Maier, Karin S, Matthew, Helen, Isaacs, Tom, Duffen, Joy, Graessner, Holm, Maetzler, Walter
Publikováno v:
BMC Neurology (2015) 15:89
Externí odkaz:
https://hdl.handle.net/10037/8847
Autor:
Ferreira, Joaquim J, Santos, Ana T., Domingos, Josefa M. M., Matthews, Helen, Isaacs, Tom, Duffen, Joy, Al-Jawad, Ahmed, Larsen, Frank, Serrano, J. Artur, Weber, Peter, Thoms, Andrea, Sollinger, Stefan, Graessner, Holm, Maetzler, Walter
© 2015 – IOS Press and the authors. All rights reserved. This article is published online with Open Access and distributed under the terms of the Creative Commons Attribution Non-Commercial License.
Background: Parkinson's disease (PD) is a n
Background: Parkinson's disease (PD) is a n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1961::879ef8f8145b31078bfeac1ee72ee55a
https://hdl.handle.net/10451/51814
https://hdl.handle.net/10451/51814
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sollinger, Stefan
Die vorliegende Arbeit beschreibt die Kalibrierung und Implementierung eines Laserprojektors als Autopointer. Ziel ist es, mit Hilfe eines Pico Laserprojektors herkömmliche Augmented Reality Methoden durch Projektion in die reale Welt zu erweitern.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1640::45edbbcb00ecf4e7f185f7bcd5b9bcc0
https://elib.dlr.de/75999/
https://elib.dlr.de/75999/
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Chemie Ingenieur Technik (CIT); Sep1990, Vol. 62 Issue 9, p768-769, 2p
Publikováno v:
In Journal of Chromatography A 1993 645(1):89-94
Publikováno v:
In Journal of Chromatography A 1992 609(1):297-304
Autor:
Godinho C; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, Lisboa, 1649-028, Portugal.; Instituto Superior de Ciências da Saúde Egas Moniz, Center for Interdisciplinary Research Egas Moniz (CiiEM), Monte de Caparica, Portugal.; CNS-Campus Neurológico Sénior, Torres Vedras, Portugal., Domingos J; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, Lisboa, 1649-028, Portugal.; CNS-Campus Neurológico Sénior, Torres Vedras, Portugal., Cunha G; Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Lisbon, Portugal., Santos AT; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, Lisboa, 1649-028, Portugal., Fernandes RM; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, Lisboa, 1649-028, Portugal.; Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Lisbon, Portugal., Abreu D; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, Lisboa, 1649-028, Portugal., Gonçalves N; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, Lisboa, 1649-028, Portugal., Matthews H; The Cure Parkinson's Trust, London, UK., Isaacs T; The Cure Parkinson's Trust, London, UK., Duffen J; The Cure Parkinson's Trust, London, UK., Al-Jawad A; HSG-IMIT, Villingen-Schwenningen, Germany., Larsen F; Norwegian Centre for Telemedicine, Tromso, Norway., Serrano A; Norwegian Centre for Telemedicine, Tromso, Norway., Weber P; Hasomed GmbH, Magdeburg, Germany., Thoms A; Hasomed GmbH, Magdeburg, Germany., Sollinger S; AbilityNet, London, UK., Graessner H; Institute for Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany., Maetzler W; Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, Center of Neurology, University of Tuebingen, Tuebingen, Germany., Ferreira JJ; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, Lisboa, 1649-028, Portugal. joaquimjferreira@gmail.com.; Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Lisbon, Portugal. joaquimjferreira@gmail.com.; CNS-Campus Neurológico Sénior, Torres Vedras, Portugal. joaquimjferreira@gmail.com.
Publikováno v:
Journal of neuroengineering and rehabilitation [J Neuroeng Rehabil] 2016 Aug 01; Vol. 13 (1), pp. 71. Date of Electronic Publication: 2016 Aug 01.
Autor:
Ferreira JJ; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal. cgcgodinho@gmail.com.; Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Lisbon, Portugal. cgcgodinho@gmail.com.; CNS - Campus Neurológico Sénior, Torres Vedras, Portugal. cgcgodinho@gmail.com., Godinho C; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal. cgcgodinho@gmail.com.; CNS - Campus Neurológico Sénior, Torres Vedras, Portugal. cgcgodinho@gmail.com.; Center for Interdisciplinary Research Egas Moniz (CiiEM), Cooperativa de Ensino Superior Egas Moniz, Monte de Caparica, Caparica, Portugal. cgcgodinho@gmail.com., Santos AT; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal. aa.teresa.ss@gmail.com., Domingos J; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal. domingosjosefa@gmail.com., Abreu D; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal. daideabreu@gmail.com., Lobo R; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal. raquel.jl.lobo@gmail.com., Gonçalves N; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal. nilzakarina@gmail.com., Barra M; Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal. marciocbarra@gmail.com., Larsen F; NST-Norwegian Centre for Integrated Care and Telemedicine, University Hospital North Norway, Tromsø, Norway. Frank.Larsen@telemed.no., Fagerbakke Ø; NST-Norwegian Centre for Integrated Care and Telemedicine, University Hospital North Norway, Tromsø, Norway. oyvind.fagerbakke@framhelse.no., Akeren I; NST-Norwegian Centre for Integrated Care and Telemedicine, University Hospital North Norway, Tromsø, Norway. ingvild.akeren@framhelse.no., Wangen H; NST-Norwegian Centre for Integrated Care and Telemedicine, University Hospital North Norway, Tromsø, Norway. Hilde.wangen@framhelse.no., Serrano JA; NST-Norwegian Centre for Integrated Care and Telemedicine, University Hospital North Norway, Tromsø, Norway. jarturserrano@gmail.com.; Department of Clinical Medicine, Faculty of Health Sciences, The Arctic University of Norway, Tromsø, Norway. jarturserrano@gmail.com., Weber P; Hasomed GmbH, Magdeburg, Germany. weber.peter@hasomed.de., Thoms A; Hasomed GmbH, Magdeburg, Germany. andrea.thoms@hasomed.de., Meckler S; HSG-IMIT, Villingen-Schwenningen, Germany. stefan.meckler@hsg-imit.de., Sollinger S; AbilityNet, London, UK. stefan.sollinger@abilitynet.org.uk., van Uem J; Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, Tuebingen, Germany. janetvanuem@gmail.com.; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. janetvanuem@gmail.com., Hobert MA; Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, Tuebingen, Germany. markus.hobert@med.uni-tuebingen.de.; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. markus.hobert@med.uni-tuebingen.de., Maier KS; Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, Tuebingen, Germany. katrin-simone.maier@student.uni-tuebingen.de.; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. katrin-simone.maier@student.uni-tuebingen.de., Matthew H; The Cure Parkinson's Trust, London, UK. helen@cureparkinsons.org.uk., Isaacs T; The Cure Parkinson's Trust, London, UK. tom@cureparkinsons.org.uk., Duffen J; The Cure Parkinson's Trust, London, UK. joy@cureparkinsons.org.uk., Graessner H; Institute for Medical Genetics and Applied Genomics, University of Tübingen, Tuebingen, Germany. holm.graessner@med.uni-tuebingen.de., Maetzler W; Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, Center of Neurology, University of Tuebingen, Tuebingen, Germany. walter.maetzler@uni-tuebingen.de.; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. walter.maetzler@uni-tuebingen.de.
Publikováno v:
BMC neurology [BMC Neurol] 2015 Jun 10; Vol. 15, pp. 89. Date of Electronic Publication: 2015 Jun 10.